[HTML][HTML] Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
KE Zane, PB Nagib, S Jalil, K Mumtaz… - World journal of …, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common cause of liver malignancy and the
fourth leading cause of cancer deaths universally. Cure can be achieved for early stage …
fourth leading cause of cancer deaths universally. Cure can be achieved for early stage …
Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score–matched study of long-term therapeutic outcomes
K Liu, H Zheng, X Sui, B Liu, M Meng, Y Feng, Q Zhu… - European …, 2023 - Springer
Objectives The therapeutic efficacy of microwave ablation (MWA) for subcapsular
hepatocellular carcinoma (HCC) has not been well characterized. We aimed to compare the …
hepatocellular carcinoma (HCC) has not been well characterized. We aimed to compare the …
[HTML][HTML] The tumor burden score may be a discriminator in microwave ablation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity …
Z Wei, K Xie, F Xu, C Dai - Frontiers in Oncology, 2024 - ncbi.nlm.nih.gov
The tumor burden score may be a discriminator in microwave ablation versus liver resection for
hepatocellular carcinoma within the Milan criteria: a propensity score matching and inverse …
hepatocellular carcinoma within the Milan criteria: a propensity score matching and inverse …
[HTML][HTML] The transcription factor TBP promotes hepatocellular carcinoma progression by activating AKT3
F Jiang, Y Lin, J Du, S Qiu, G Luo… - American Journal of …, 2023 - ncbi.nlm.nih.gov
The present work was performed to clarify the role of TATA-binding protein (TBP) in
hepatocellular carcinoma (HCC). TBP expression in adjacent liver tissues and HCC tissue …
hepatocellular carcinoma (HCC). TBP expression in adjacent liver tissues and HCC tissue …
[HTML][HTML] Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization
G Chen, H Chen, X Huang, S Cheng, S Zheng, Y Wu… - Medicina, 2022 - mdpi.com
Background and Objectives: The recurrence outcome in patients who underwent microwave
ablation (MWA) with or without transarterial chemoembolization (TACE) for hepatocellular …
ablation (MWA) with or without transarterial chemoembolization (TACE) for hepatocellular …
[PDF][PDF] Autologous liver transplantation for unresectable hepatobiliary malignancies in enhanced recovery after surgery model
W Liu, G Li, Y Jin, Y Feng, Z Gao, X Liu, B Zhou… - Open …, 2024 - degruyter.com
Ex vivo liver resection combined with autologous liver transplantation offers the opportunity
to treat otherwise unresectable hepatobiliary malignancies and has been applied in clinic …
to treat otherwise unresectable hepatobiliary malignancies and has been applied in clinic …